Skip to main content

Grafa News and Videos — Page 1524

Latest

Grafa

LifeMD expands weight management program with launch of Eli Lilly’s Foundayo oral GLP-1

LifeMD (NASDAQ:LFMD), a leader in virtual primary care, announced on April 10, 2026, the addition of Eli Lilly’s newly approved oral weight-loss medication, Foundayo (orforglipron), to its comprehensive weight management program.

Read more: LifeMD expands weight management program with launch of Eli Lilly’s Foundayo oral GLP-1

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift